About Tenaya Therapeutics
Tenaya Therapeutics is a company based in San Francisco (United States) founded in 2016 by Benoit Bruneau and Bruce Conklin.. Tenaya Therapeutics has raised $142 million across 3 funding rounds from investors including State of California, The Column Group and Casdin Capital. The company has 97 employees as of December 31, 2024. Tenaya Therapeutics offers products and services including Gene Therapy Platform, Cellular Regeneration, and Precision Medicine. Tenaya Therapeutics operates in a competitive market with competitors including Senti Biosciences, Portola Pharma, Cellino, Arrakis Therapeutics and Aegerion, among others.
- Headquarter San Francisco, United States
- Employees 97 as on 31 Dec, 2024
- Founders Benoit Bruneau, Bruce Conklin
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tenaya Therapeutics, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-111.13 M10.44as on Dec 31, 2024
-
EBITDA
$-107.48 M12.27as on Dec 31, 2024
-
Total Equity Funding
$142 M (USD)
in 3 rounds
-
Latest Funding Round
$8 M (USD), Grant
Feb 03, 2025
-
Investors
State of California
& 3 more
-
Employee Count
97
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Tenaya Therapeutics
Tenaya Therapeutics is a publicly listed company on the NASDAQ with ticker symbol TNYA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Tenaya Therapeutics
Tenaya Therapeutics offers a comprehensive portfolio of products and services, including Gene Therapy Platform, Cellular Regeneration, and Precision Medicine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops gene therapies for treating cardiomyopathies and heart conditions
Focuses on regenerating heart cells to combat disease progression
Tailors therapies based on genetic data for heart disease patients
Unlock access to complete
Unlock access to complete
Funding Insights of Tenaya Therapeutics
Tenaya Therapeutics has successfully raised a total of $142M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $8 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $8.0M
-
First Round
First Round
(06 Dec 2016)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Grant - Tenaya Therapeutics | Valuation |
investors |
|
| Oct, 2019 | Amount | Series B - Tenaya Therapeutics | Valuation | Casdin Capital | |
| Dec, 2016 | Amount | Series A - Tenaya Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tenaya Therapeutics
Tenaya Therapeutics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include State of California, The Column Group and Casdin Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Early-stage investments in US life science startups are focused on.
|
Founded Year | Domain | Location | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tenaya Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tenaya Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tenaya Therapeutics Comparisons
Competitors of Tenaya Therapeutics
Tenaya Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Portola Pharma, Cellino, Arrakis Therapeutics and Aegerion, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cardiovascular and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Innovative pharmaceuticals for cardiovascular and metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tenaya Therapeutics
Frequently Asked Questions about Tenaya Therapeutics
When was Tenaya Therapeutics founded?
Tenaya Therapeutics was founded in 2016.
Where is Tenaya Therapeutics located?
Tenaya Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Tenaya Therapeutics a funded company?
Tenaya Therapeutics is a funded company, having raised a total of $142M across 3 funding rounds to date. The company's 1st funding round was a Series A of $50M, raised on Dec 06, 2016.
How many employees does Tenaya Therapeutics have?
As of Dec 31, 2024, the latest employee count at Tenaya Therapeutics is 97.
What does Tenaya Therapeutics do?
Tenaya Therapeutics was founded in 2016 and is based in San Francisco, United States. Focus is placed on the biotechnology sector, where regenerative and gene therapeutics are developed to address heart failure conditions. The pipeline encompasses MYBPC3 for genetic hypertrophic cardiomyopathy, PKP2 for genetic arrhythmogenic right ventricular cardiomyopathy, DWORF for dilated cardiomyopathy, and HDAV6i for heart failure with preserved ejection fraction. Operations center on advancing these targeted treatments.
Who are the top competitors of Tenaya Therapeutics?
Tenaya Therapeutics's top competitors include Senti Biosciences, Athira Pharma and Orca Bio.
What products or services does Tenaya Therapeutics offer?
Tenaya Therapeutics offers Gene Therapy Platform, Cellular Regeneration, and Precision Medicine.
Is Tenaya Therapeutics publicly traded?
Yes, Tenaya Therapeutics is publicly traded on NASDAQ under the ticker symbol TNYA.
Who are Tenaya Therapeutics's investors?
Tenaya Therapeutics has 4 investors. Key investors include State of California, The Column Group, Casdin Capital, and Google Ventures.
What is Tenaya Therapeutics's ticker symbol?
The ticker symbol of Tenaya Therapeutics is TNYA on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.